|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.124 +0.035 (+39.326%) | 2025/06 - Interim HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (49,873) | 2,183 | (26,372) | (53,814) |
| Net Cash from / (used in) Investing Activities | -- | (4,656) | (70,947) | (17,246) | (147,737) |
| Net Cash from / (used in) Financing Activities | -- | 35,743 | (26,212) | 102,631 | 123,170 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (18,786) | (94,976) | 59,013 | (78,381) |
| Cash & Cash Equivalents at beginning of period | -- | 34,493 | 128,098 | 60,198 | 142,440 |
| Effect of Foreign Exchange Rate Changes | -- | 610 | 1,371 | 8,887 | (3,861) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 16,317 | 34,493 | 128,098 | 60,198 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 11,243 |
| %Change | -- |
| EPS / (LPS) | HKD 0.004 |
| NBV Per Share ($) | HKD -0.023 |